Cell Cycle Checkpoint and DNA Damage Response Defects as Anticancer Targets: From Molecular Mechanisms to Therapeutic Opportunities

Feb 15, 2017 by in ONCOLOGY Comments Off on Cell Cycle Checkpoint and DNA Damage Response Defects as Anticancer Targets: From Molecular Mechanisms to Therapeutic Opportunities

Fig. 3.1 The cell cycle and its checkpoints. Cyclins are individually synthesised and degraded in a phase distinctive manner and bind and activate specific Cdks which coordinates the sequential progression…

read more

p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities

Feb 15, 2017 by in ONCOLOGY Comments Off on p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities

Fig. 4.1 The central part of the figure represents the p53 protein indicating its main domains: the N-terminal transactivation domain, the proline-rich domain, a central DNA binding core and a…

read more

MicroRNA Regulated Stress Responses in Cancer

Feb 15, 2017 by in ONCOLOGY Comments Off on MicroRNA Regulated Stress Responses in Cancer

Fig. 6.1 A brief history of microRNA research milestone The function of miRNAs requires a sequence specific match to their target mRNA. The majority of match pairs are composed of…

read more

Integrating Proteotoxic Stress Response Pathways for Induction of Cell Death in Cancer Cells: Molecular Mechanisms and Therapeutic Opportunities

Feb 15, 2017 by in ONCOLOGY Comments Off on Integrating Proteotoxic Stress Response Pathways for Induction of Cell Death in Cancer Cells: Molecular Mechanisms and Therapeutic Opportunities

Fig. 9.1 The three main signaling pathways of UPR. UPR begins in the ER. GRP78 binds the main stress response proteins, IRE1α, ATF6, and PERK in an inhibitory fashion under…

read more
Get Clinical Tree app for offline access